P/E ratio for Fresenius Medical Care (FMS)
P/E ratio as of April 2024 (TTM): 23.5
According to Fresenius Medical Care's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.5366. At the end of 2022 the company had a P/E ratio of 13.6.
P/E ratio history for Fresenius Medical Care from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 13.6 | -19.05% |
| 2021 | 16.9 | -7.35% |
| 2020 | 18.2 | 9.25% |
| 2019 | 16.7 | 94.41% |
| 2018 | 8.57 | -60.75% |
| 2017 | 21.8 | 6.84% |
| 2016 | 20.4 | -17.46% |
| 2015 | 24.8 | 14.97% |
| 2014 | 21.5 | 8.98% |
| 2013 | 19.8 | 9.37% |
| 2012 | 18.1 | -2.88% |
| 2011 | 18.6 | 6.84% |
| 2010 | 17.4 | 0.04% |
| 2009 | 17.4 | 2.44% |
| 2008 | 17.0 | -23.07% |
| 2007 | 22.1 | -11.87% |
| 2006 | 25.1 | 26.93% |
| 2005 | 19.7 | -4.86% |
| 2004 | 20.7 | -2.96% |
| 2003 | 21.4 | 65.9% |
| 2002 | 12.9 | -40.88% |
| 2001 | 21.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 18.6 | -21.11% | 🇺🇸 USA |
 Baxter BAX | 7.74 | -67.10% | 🇺🇸 USA |
 DaVita DVA | 24.4 | 3.84% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | 48.2 | 104.84% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 18.6 | -20.86% | 🇺🇸 USA |
 Teleflex TFX | 24.1 | 2.45% | 🇺🇸 USA |
 LabCorp LH | 26.5 | 12.69% | 🇺🇸 USA |
 Rockwell Medical
RMTI | -1.68 | -107.15% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.